Product Information

BROMFENAC SOD 0.075% EYE DROP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $25.3598 per ML under NDC 68180043401. Its NADAC has been published 130 times since May 22, 2024.

FDA first approved this application on Feb 2, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BROMFENAC SOD 0.075% EYE DROP

BROMFENAC
$25.3598per ML

Strength

.75 mg/mL

NDC

68180043401

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

10/21/2026

Active Ingredients

BROMFENAC SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211239

FDA Approved

2/2/2024

TE Code

AB

On Market Since

2/12/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for BROMFENAC SOD 0.075% EYE DROP has been published 130 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$25.3598 per ML
All-time high$26.7005 (Mar 11, 2026)
All-time low$19.7579 (Dec 18, 2024)
52-week high$26.7005
52-week low$23.5416
Median price$24.0979
Average price$23.7431
Largest weekly change-22.0% (Jul 17, 2024)
Weeks tracked130
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

+4.0%

3M

+5.2%

6M

+5.9%

1Y

-1.0%

3Y

N/A

5Y

N/A

All

+1.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BROMFENAC market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BROMFENAC SOD 0.075% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SOD 0.075% EYE DROP, manufactured by Lupin Pharmaceuticals Inc., is $25.3598 per ML (NDC 68180043401), effective Nov 11, 2026.

How has the price of BROMFENAC SOD 0.075% EYE DROP changed over time?

Over the history we have for it, the NADAC for BROMFENAC SOD 0.075% EYE DROP has held within roughly two percent of its current level. It has been tracked across 130 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for BROMFENAC SOD 0.075% EYE DROP?

Since May 22, 2024, the NADAC for BROMFENAC SOD 0.075% EYE DROP has ranged from a low of $19.7579 (Dec 18, 2024) to a high of $26.7005 (Mar 11, 2026), with a median of $24.0979 per ML.

Are there cheaper alternatives to BROMFENAC SOD 0.075% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SOD 0.075% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BROMFENAC SOD 0.075% EYE DROP?

BROMFENAC SOD 0.075% EYE DROP (NDC 68180043401) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.